What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.
Sonia Roldan MunozDouwe PostmusSieta T de VriesLiana Gross-MartirosyanPriya BahriHans L HillegePeter G M MolPublished in: Drug safety (2023)
The opinion regarding the need to communicate safety issues was influenced by the concern of regulators. Regulators' concern was influenced by the characteristics of the safety issue, demographic characteristics, and attitudes. Diverse groups of experts regarding such factors would ensure that various views are incorporated in risk communication decisions.